1. Home
  2. TELA vs CELU Comparison

TELA vs CELU Comparison

Compare TELA & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

SELL

Current Price

$0.69

Market Cap

31.4M

Sector

Health Care

ML Signal

SELL

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$0.44

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TELA
CELU
Founded
2012
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.4M
26.5M
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
TELA
CELU
Price
$0.69
$0.44
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $2.00
N/A
AVG Volume (30 Days)
122.1K
★ 182.4K
Earning Date
11-10-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 37.59
N/A
EPS
N/A
★ 0.04
Revenue
★ $80,275,000.00
$26,550,000.00
Revenue This Year
N/A
$165.42
Revenue Next Year
$8.83
$305.36
P/E Ratio
★ N/A
$11.70
Revenue Growth
★ 15.84
N/A
52 Week Low
$0.50
$0.46
52 Week High
$1.50
$2.55

Technical Indicators

Market Signals
Indicator
TELA
CELU
Relative Strength Index (RSI) 35.19 25.58
Support Level $0.60 N/A
Resistance Level $0.98 $0.83
Average True Range (ATR) 0.12 0.10
MACD -0.01 -0.01
Stochastic Oscillator 9.14 6.38

Price Performance

Historical Comparison
TELA
CELU

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

About CELU Celularity Inc.

Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.

Share on Social Networks: